Previous studies have revealed that SMAD7 acts as a tumor suppressor in a variety of cancers, including gastric cancer (38), bladder cancer (39), and hepatocellular carcinoma (40). This evidence concerns the gene SMAD7 and urinary bladder carcinoma.